In Practise Logo
In Practise Logo - Blue
In Practise Logo
IP Interview
Published August 5, 2024

Danaher & the Bioprocessing FDA Approval Process

Executive Bio

Former Head of Sales, GE Life Sciences

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

But in terms of the customer, let's say, at the drug discovery phase, are they focusing more on the resins or the media, or are both equally critical?

Equally. Yes, and that's why you have upstream R&D, upstream process development, and similar functions. You run downstream processes in parallel because both are critical elements. You need to ensure they are optimally functional and stable. Stability is key. The company is trying to instill an industrial mindset across the organization. Everyone will benefit by thinking of this as a product, not just fun work in the lab. Both upstream media and downstream resins are equally mission-critical. 

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.